| Date Filed | Type | Description |
| 08/15/2023 |
4
| Sjuts Dustin S (President) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 22,620 shares
@ $0
Paid exercise price by delivering 8,901 shares
@ $18.91, valued at
$168.3k
|
|
| 07/05/2023 |
4
| Sjuts Dustin S (President) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 1,000 shares
@ $15.606, valued at
$15.6k
|
|
| 06/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/16/2023 |
4
| Sjuts Dustin S (President) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 52,395 shares
@ $0
Sold 21,015 shares
@ $34.5469, valued at
$726k
|
|
| 05/12/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/17/2023 |
4
| Sjuts Dustin S (President) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 2,967 shares
@ $30.65, valued at
$90.9k
|
|
| 03/09/2023 |
4
| Sjuts Dustin S (President) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 52,396 shares
@ $0
Sold 21,508 shares
@ $31.5863, valued at
$679.4k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2023 |
4
| Sjuts Dustin S (President) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 605 shares
@ $12.1805, valued at
$7.4k
|
|
| 12/16/2022 |
4
| Sjuts Dustin S (President) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 2,916 shares
@ $21.5, valued at
$62.7k
|
|
| 07/05/2022 |
4
| Sjuts Dustin S (President) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 1,000 shares
@ $11.747, valued at
$11.7k
|
|
| 03/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2022 |
4
| Sjuts Dustin S (President) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 2,134 shares
@ $13.35, valued at
$28.5k
Paid exercise price by delivering 295 shares
@ $13.35, valued at
$3.9k
|
|
| 02/04/2022 |
4
| Sjuts Dustin S (President) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 57,016 options to buy
@ $13.08, valued at
$745.8k
|
|
| 12/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2021 |
4
| Sjuts Dustin S (President) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 35,920 shares
@ $0 |
|
| 07/02/2021 |
4
| Sjuts Dustin S (Chief Commercial Officer) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Acquired 882 shares
@ $24.089, valued at
$21.2k
|
|
| 04/16/2021 |
4
| Sjuts Dustin S (Chief Commercial Officer) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 411 shares
@ $28.16, valued at
$11.6k
|
|
| 02/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2020 |
4
| Sjuts Dustin S (Chief Commercial Officer) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 562 shares
@ $26.75, valued at
$15k
|
|
| 10/02/2020 |
4
| Sjuts Dustin S (Chief Commercial Officer) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 17,500 shares
@ $0
Paid exercise price by delivering 6,051 shares
@ $25.14, valued at
$152.1k
|
|
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/17/2020 |
4
| Sjuts Dustin S (Chief Commercial Officer) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 432 shares
@ $14.8, valued at
$6.4k
|
|
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/24/2020 |
4
| Sjuts Dustin S (Chief Commercial Officer) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 20,000 shares
@ $0
Granted 100,000 options to buy
@ $22.32, valued at
$2.2M
|
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2019 |
4
| Sjuts Dustin S (Chief Commercial Officer) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 576 shares
@ $15.99, valued at
$9.2k
|
|
| 12/10/2019 |
3
| Sjuts Dustin S (Chief Commercial Officer) has filed a Form 3 on Revance Therapeutics, Inc. |